Clinical Trial Update: Cholesterol Reduction in Seniors Program (CRISP) [Phase 2]

View source ↗

Summary

This is an update for the Cholesterol Reduction in Seniors Program (CRISP), a Phase 2 trial evaluating cholesterol-lowering strategies in seniors. The study sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Cardiovascular Disease
• Coronary Artery Disease
• Heart Disease
• Hypercholesterolemia
• Myocardial Ischemia

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Atherosclerosis, Cardiovascular Diseases | Phase 2 | Status: COMPLETED